Risk Factors for Tuberculosis among Human Immunodeficiency Virus-infected Persons. A Case-control Study in Belo Horizonte, Minas Gerais, Brazil (1985-1996)

Memorias do Instituto Oswaldo Cruz

Volumn 95, Issue 4, 2000, Pages 437-443

  De Castro Toledo Jr , Antonio Carlos ^a   Greco, Dirceu Bartiolomeu ^a   Antunes, Carlos Maurício Figueiredo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antiretroviral therapy; Brazil; CD4; Chemoprophylaxis; Human immunodeficiency virus aids; Minas Gerais; PPD skin test; Risk factors; Tuberculosis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAZIL; CASE CONTROL STUDY; CONFIDENCE INTERVAL; EPIDEMIOLOGY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; RISK FACTOR;

ADOLESCENT; ADULT; AIDS-RELATED COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; BRAZIL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0034220145     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02762000000400001     Document Type: Article

References (34)

1. Ackah A, Coulibaly D, Digbeu H, Diallo K, Vetter K, Coulibaly I, Greenberg A, De Cock K 1995. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'lvoire. Lancet 345: 607-610.
2. Arachi A 1991. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72: 1-6.
3. Barnes PF, Barrows SA 1993. Tuberculosis in the 1990s. Ann Intern Med 119: 400-410.
4. Borleffs JC, Schneider MM, Hoepelman IM 1998. A changed pattern of opportunistic infections and malignancies in HIV- seropositive patients after the introduction of intensive anti-HIV-combination therapy. Ned Tijdschr Geneeskd 142: 2395-9.
5. Campos-Filho N, Franco EL 1989. A microcomputer program for multiple logistic regression by uncoditional and conditional maximum likelihood methods. Amer J Epidemiol 129: 439-444.
6. Cantwell MF, Snider DEJ, Cauthen GM, Onorato IM 1994. Epidemiology of tuberculosis in the United States, 1985 through 1992.JAMA 272: 535-539.
7. CDC - Centers for Disease Control and Prevention 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36: 1S-15S.
8. Citron KM 1988. Control and prevention of tuberculosis in Britain. Br Med Bull 44: 704-716.
9. Ellner J, Hinman A, Dooley S, Fischl M, Sepkowitz K, Goldberger M, Schinnick T, Iseman M, Jacobs WJ 1993. Tuberculosis symposium: emerging problems and promise. J Infect Dis 168: 537-551.
10. Gerhardt Filho G, Hijjar MA 1993. Aspectos epidemiológicos da tuberculose no Brasil. J Pneumol 10:4-10.
11. Halsey N, Coberly J, Desormeaux J, Losikoff P, Atkinson J, Moulton L, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R, Chaisson R 1998. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 351: 786-792.
12. Hijjar MA 1992. Epidemiologia da tuberculose no Brasil. Informe Epidemiológico do SUS Novembro: 53-87.
13. Hosmer DW, Lemeshow S 1989. Applied Logistic Regression, Wiley Interscience, New York, 307 pp.
14. Kantor IN, Astarloa L, Gonzalez Montaner LJ 1994. Asociación entre tuberculosis e infección por virus de la inmunodeficiencia humana en la Argentina. Bol Oficina Sanit Panam 116: 356-366.
15. Kritski A, Dalcolmo M, Del Bianco R, Melo FM, Pinto W, Schechther M, Castelo E 1995. Associaçào tuberculose e infecçào pelo HIV no Brasil. Bol Oficina Sanit Panam 118: 542-554.
16. Ministério da Saúde 1999. AIDS, Boletim Epidemiologico 12.
17. Nardell E, McInn B, Thomas B, Weidhass S 1986. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Eng J Med 315: 1570-5.
18. Nunn P, Elliott AM, McAdam KP 1994. Impact of human immunodeficiency virus on tuberculosis on developing countries. Thorax 49: 511-518.
19. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DEJ 1989. Tuberculosis in the United States. JAMA 262: 385-389.
20. Selwyn PA, Hartel D, Lewis VA, Schoenbaun EE, Vermund SH, Klein RS, Walker AT, Friedland GH 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Eng J Med 320: 545-550.
21. Sepkowitz KA, Raffalli J 1994. Tuberculosis at the end of the twentieth century. Ear J Clin Microbiol Infect Dis 13: 902-907.
22. Shafer B, Bloch A, Larkin C, Vasudavan V, Seligman S, Dehovitz J, DiFerdinando G, Stoneburner R, Cauthen G 1996. Predictors of survival in HIV-infected tuberculosis patients. AIDS 10: 269-272.
23. Sparano JA, Anand K, Desai J, Mitnick RJ, Kalkut GE, Hanau LH 1999. Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. J Acquir Immune Defic Syndr 21 (Suppl. 1): S18-22.
24. Stead WW 1978. Undetected tuberculosis in prison. Source of infection of community at large. JAMA 240: 2544-2547.
25. Stead WW, Lofgren JP, Warren E, Thomas C 1985. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Eng J Med 312: 1483-1487.
26. Stites D 1991. Clinical laboritory methods for detection of cellular immunity. In D Stiles, A Terr (eds), Basic and Clinical Immunology, East Norwalk, Appleton & Lange, p. 263-283.
27. Styblo K 1989. Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis 11:S339-S346.
28. Toledo Jr. AC, Vitoria MAA, Castro AL, Padua CAJ, Nunes CM, Greco DB 1994. PPD as a predictor of tuberculosis in HIV(+) persons in Brazil. X International Conference on AIDS, Tokio.
29. van Rie A, Warren R, Richardson M, Victor T, Gie R, Enarson D, Beyers N, van Helden P 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Eng J Med 341: 1174-1179.
30. Viciana P, Miralles-Martin P, Knobel H, Gatell JM 1998. Prevention of opportunistic infections in the protease inhibitor era. Enferm Infecc Microbiol Clin 16: 1-10.
31. Whalen C, Johnson J, Okwera A, Hom D, Huebner R, Mugyenyi P, Mugerwa R, Ellner J, for the Uganda-Case Western Reserve University Research Collaboration 1997a. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Eng J Med 337: 801-808.
32. Whalen C, Horsburgh CJ, Horn D, Lahart C, Simberkoff M, Ellner J 1997b. Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS 11: 455-460.
33. Wilkinson D, Squire S, Garner P 1998. Effect of preventive treatment for tuberculosis in adults infected with HIV: systemic review of randomised placebo controlled trials. BMJ 317: 625-629.
34. Zacarias F, Gonzalez RS, Cuchi P, Yanez A, Peruga A, Mazin R, Betts C, Weissenbacher M 1994. El SIDA y su interación con la tuberculosis en America Latina y el Caribe. Bol Oficina Sanit Panam 116: 250-263.